341 related articles for article (PubMed ID: 17692648)
1. Hepatitis C virus-related cirrhosis as a significant mortality factor in intention-to-treat analysis in liver transplantation.
Gringeri E; Vitale A; Brolese A; Zanus G; Boccagni P; Neri D; Valmasoni M; D'Amico F; Ciarleglio FA; Carraro A; Pauletto A; Violi P; Bassi D; D'Amico F; D'Amico DF; Cillo U
Transplant Proc; 2007; 39(6):1901-3. PubMed ID: 17692648
[TBL] [Abstract][Full Text] [Related]
2. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
[TBL] [Abstract][Full Text] [Related]
3. Molecular adsorbents recirculating system treatment in acute-on-chronic hepatitis patients on the transplant waiting list improves model for end-stage liver disease scores.
Novelli G; Rossi M; Pugliese F; Poli I; Ruberto E; Martelli S; Nudo F; Morabito V; Mennini G; Berloco PB
Transplant Proc; 2007; 39(6):1864-7. PubMed ID: 17692635
[TBL] [Abstract][Full Text] [Related]
4. Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.
Belli LS; Burroughs AK; Burra P; Alberti AB; Samonakis D; Cammà C; De Carlis L; Minola E; Quaglia A; Zavaglia C; Vangeli M; Patch D; Dhillon A; Cillo U; Guido M; Fagiuoli S; Giacomoni A; Slim OA; Airoldi A; Boninsegna S; Davidson BR; Rolles K; Pinzello G
Liver Transpl; 2007 May; 13(5):733-40. PubMed ID: 17370330
[TBL] [Abstract][Full Text] [Related]
5. Factors that predict survival in patients with cirrhosis considered for liver transplantation.
Samada Suarez M; Hernández Perera JC; Ramos Robaina L; Barroso Márquez L; González Rapado L; Cepero Valdés M; Hernández Rivero H; Abdo Cuza A; Valdés AR; Pérez Bernal J; Bernardos A
Transplant Proc; 2008 Nov; 40(9):2965-7. PubMed ID: 19010161
[TBL] [Abstract][Full Text] [Related]
6. Liver transplantation for HCV-associated liver cirrhosis: predictors of outcomes in a population with significant genotype 3 and 4 distribution.
Zekry A; Whiting P; Crawford DH; Angus PW; Jeffrey GP; Padbury RT; Gane EJ; McCaughan GW;
Liver Transpl; 2003 Apr; 9(4):339-47. PubMed ID: 12682883
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.
Ferraz-Neto BH; Hidalgo R; Thomé T; Melo VA; Lobue A; Zurstrassen MP; Moraes JM; Meira-Filho SP; Rezende MB; Fonseca LE; Pandullo FL; Soeiro FS; Afonso RC
Transplant Proc; 2007 Oct; 39(8):2511-3. PubMed ID: 17954160
[TBL] [Abstract][Full Text] [Related]
8. Bilirubin appears to be the only independent variable affecting mortality on liver transplant waiting list if waiting time exceeds 1 year.
Lee YM; Wai CT; Da Costa M; Lee KH; Sutedja D; Tan KC; Isaac J; Lim SG
Transplant Proc; 2005 Dec; 37(10):4365-6. PubMed ID: 16387121
[TBL] [Abstract][Full Text] [Related]
9. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
[TBL] [Abstract][Full Text] [Related]
10. Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients.
Guo L; Orrego M; Rodriguez-Luna H; Balan V; Byrne T; Chopra K; Douglas DD; Harrison E; Moss A; Reddy KS; Williams JW; Rakela J; Mulligan D; Vargas HE
Liver Transpl; 2006 Apr; 12(4):560-5. PubMed ID: 16555313
[TBL] [Abstract][Full Text] [Related]
11. Severe recurrent hepatitis C after liver retransplantation for hepatitis C virus-related graft cirrhosis.
Berenguer M; Prieto M; Palau A; Rayón JM; Carrasco D; Juan FS; López-Labrador FX; Moreno R; Mir J; Berenguer J
Liver Transpl; 2003 Mar; 9(3):228-35. PubMed ID: 12619018
[TBL] [Abstract][Full Text] [Related]
12. Determinants of outcome of compensated hepatitis C virus-related cirrhosis.
Serfaty L; Aumaître H; Chazouillères O; Bonnand AM; Rosmorduc O; Poupon RE; Poupon R
Hepatology; 1998 May; 27(5):1435-40. PubMed ID: 9581703
[TBL] [Abstract][Full Text] [Related]
13. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
Cuomo O; Perrella A; Arenga G
Transplant Proc; 2008; 40(6):1906-9. PubMed ID: 18675085
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C impairs survival following liver transplantation irrespective of concomitant hepatocellular carcinoma.
Melum E; Friman S; Bjøro K; Rasmussen A; Isoniemi H; Gjertsen H; Bäckman L; Oksanen A; Olausson M; Duraj FF; Ericzon BG
J Hepatol; 2007 Dec; 47(6):777-83. PubMed ID: 17714825
[TBL] [Abstract][Full Text] [Related]
15. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation.
Llovet JM; Fuster J; Bruix J
Hepatology; 1999 Dec; 30(6):1434-40. PubMed ID: 10573522
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of waitlisted patients for liver transplantation at a liver transplantation unit in the city of Ribeirão Preto, São Paulo, Brazil, especially considering Child and Model for End Stage Liver Disease (MELD) scores.
Teixeira AC; Souza FF; Sankarankutty AK; Martinelli AL; Castro E Silva O
Transplant Proc; 2007 Mar; 39(2):387-9. PubMed ID: 17362738
[TBL] [Abstract][Full Text] [Related]
17. Survival after liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease and pre-model for end-stage liver disease eras and the independent impact of hepatitis C virus.
Thuluvath PJ; Maheshwari A; Thuluvath NP; Nguyen GC; Segev DL
Liver Transpl; 2009 Jul; 15(7):754-62. PubMed ID: 19562709
[TBL] [Abstract][Full Text] [Related]
18. Liver transplant recipients mortality on the waiting list: long-term comparison to Child-Pugh classification and MELD.
Boin IF; Leonardi MI; Pinto AO; Leme RS; Udo E; Stucchi RS; Soares EC; Leonardi LS
Transplant Proc; 2004 May; 36(4):920-2. PubMed ID: 15194317
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of living donor liver transplantation for hepatitis C virus (HCV)-positive patients.
Takada Y; Haga H; Ito T; Nabeshima M; Ogawa K; Kasahara M; Oike F; Ueda M; Egawa H; Tanaka K
Transplantation; 2006 Feb; 81(3):350-4. PubMed ID: 16477219
[TBL] [Abstract][Full Text] [Related]
20. The natural history of hepatitis C cirrhosis after liver transplantation.
Firpi RJ; Clark V; Soldevila-Pico C; Morelli G; Cabrera R; Levy C; Machicao VI; Chaoru C; Nelson DR
Liver Transpl; 2009 Sep; 15(9):1063-71. PubMed ID: 19718647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
